HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predominance of sialomucin secretion in malignant and premalignant pancreatic lesions.

Abstract
Sialomucin and sulphomucin-secreting cells were studied in the normal and pathologic human pancreas with the high iron diamine-alcian blue technique which allows differentiation between the two types of mucin. In six normal autopsy pancreata, only sulphomucin was found. In benign lesions of either calcifying chronic pancreatitis (seven cases) or obstructed chronic pancreatitis (six cases), sulphomucins were widely predominant. In contrast, malignant lesions (pancreatic adenocarcinoma [12 cases], cystadenocarcinoma [two cases]) or premalignant lesions (mucinous cystadenoma [one case], ductectatic mucinous cystadenoma [four cases], villous adenoma of the main pancreatic duct [two cases]) showed a predominant sialomucin secretion, except for three poorly differentiated pancreatic carcinomas that did not show mucin staining. The sialomucin positivity was not observed at distance from the malignant lesions. In one case of benign enteroid cyst, sulphomucins predominated. These findings indicate a preponderance of sialomucin secretion in malignant or premalignant pancreatic lesions.
AuthorsL Xerri, M J Payan, R Choux, N Gros, D Figarella-Branger, H Sarles
JournalHuman pathology (Hum Pathol) Vol. 21 Issue 9 Pg. 927-31 (Sep 1990) ISSN: 0046-8177 [Print] United States
PMID1697555 (Publication Type: Journal Article)
Chemical References
  • Mucins
  • Sialomucins
  • sulfomucin
Topics
  • Chronic Disease
  • Histocytochemistry
  • Humans
  • Mucins (metabolism)
  • Pancreas (metabolism)
  • Pancreatic Ducts (metabolism)
  • Pancreatic Neoplasms (metabolism)
  • Pancreatitis (metabolism)
  • Sialomucins
  • Staining and Labeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: